The New Cancer Treatment For Prostate Cancer

The new treatment for prostate cancer has beenpersuades the immune system of the body to battle
given an authorization by the Food and Drugagainst the tumor. This type of therapy is known as
Administration of the USA drug regulators have madeimmunotherapy. A comparable treatment for
the decision just recently. The new treatmentmalignancy is assumed to be along the way.
enables the human in battling prostrate cancer. TheProvenge can be most helpful to patients who were
medicine is called Provenge which was developed toeffectively treated by the regular forms of therapy.
fight prostate tumor in its later stages.According to the Chief Executive of The Prostate
The new drug costs around ninety three thousandCancer Charity, John Neate, treating cancer by
dollars, it very expensive. The dosage intended formeans of annoying reactions from the immune
every patient must be set in accordance with theirsystem of the body was a clear center of attention
needs. The drug has not been considered to take theof study for several years and it is optimistic to see
place of some treatments that are already beingthe theory being interpreted into a new therapy for
used, but can be accessible along with somemen. But he gave a warning of the tests ahead in
treatments. Trials have been confirmed thatthe use of such treatment: "The information that this
Provenge can give a patient with prostate cancer ankind of immunotherapy can offer extra survival
extra four months to live while chemotherapy canadvantage is promising. On the other hand, this
give only three months in average.process of treatment can give multiple challenges.
Five hundred twelve men joined in the therapeuticThese intricate processes require the removal of the
trials intended for the medicine established byimmune cells of the patient from blood circulation and
Dendreon, a company created in early 90's by Dr.expose them to any protein which is found in most
Samuel Strober and also Dr. Edgar Engleman, both ofprostate tumors, associated into a resistant
them are Stanford professors. The new treatmentstimulating substance".